A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1997
11/19/1997	EP0807104A2 Heterocyclic compounds possessing 5ht 2c? receptor antagonist activity
11/19/1997	EP0807101A1 2-aminoindans as selective dopamine d3 ligands
11/19/1997	EP0682657B1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE
11/19/1997	CN1165031A Traditional Chinese prescription medicine for treatment of cerebral paralysis disease
11/19/1997	CN1165006A Health food and medicine for treatment of child restless syndrome
11/19/1997	CN1165005A Anti-neurosism preparation and its preparing technology
11/19/1997	CN1165000A Method of reducing tissue damage associated with ischemia
11/18/1997	US5688960 Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
11/18/1997	US5688957 (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1997	US5688955 Analgesics
11/18/1997	US5688952 Vasoconstrictor intermediates
11/18/1997	US5688950 Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
11/18/1997	US5688945 Compounds
11/18/1997	US5688943 Cholecystokinin antagonist; antiulcer agents; psychological drugs; anxiolytic agents; controlling appetite
11/18/1997	US5688829 Mixture containing dimethylacetamide, benzyl benzoate and ethyl oleate
11/18/1997	US5688820 Nervous system disorders; psychological disorders
11/18/1997	US5688818 Enzyme inhibitors
11/18/1997	US5688814 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides
11/18/1997	US5688811 Psychological disorders; nervous system disorders
11/18/1997	US5688809 5-heteroarylindole derivatives
11/18/1997	US5688806 Antiinflammatory agents and central nervous system disorders
11/18/1997	US5688804 3-Benzylamino-2-phenyl-piperidine derivatives as substance P receptor antagonists
11/18/1997	US5688803 Tricyclic dicarbonyl derivatives
11/18/1997	US5688802 Treatment of alzheimer's disease, organic brain syndrome, parkinson's disease, senile dementia
11/18/1997	US5688799 9-Hydroxy-pyrido 1,2-a!pyrimidin-4-one ether derivatives
11/18/1997	US5688798 Psychotic illness such as schizophrenia
11/18/1997	US5688793 Pyridazino 4',5':3,4!pyrrolo- 2,1-a!-isoquinolines and the use thereof for preparing pharmaceutical preparations
11/18/1997	US5688790 Phenylpyrrole derivatives and their use as antipsychotic agents
11/18/1997	US5688788 N-substituted azaheterocyclic carboxylic acids and esters thereof
11/18/1997	US5688773 Method of selectively destroying neoplastic cells
11/18/1997	US5688654 GABA a receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to GABAa receptor subtypes
11/13/1997	WO1997042224A1 Neurotactin and uses therefor
11/13/1997	WO1997042191A1 Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
11/13/1997	WO1997042190A1 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
11/13/1997	WO1997042183A1 Benzofuryl derivatives and their use
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	WO1997041879A1 Enhancement of sleep with a growth hormone secretagogue
11/13/1997	WO1997041874A1 Phosphatidic acid-comprising compositions
11/13/1997	WO1997041858A1 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
11/13/1997	WO1997033996A3 Human bikunin
11/13/1997	WO1997027177A3 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists
11/13/1997	WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
11/13/1997	DE19619036A1 Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with carbo- or heterocyclic substituent at C-25, process for their preparation and the use thereof for producing medicaments
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253864A1 Neurotactin and uses therefor
11/13/1997	CA2253473A1 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
11/13/1997	CA2253390A1 Enhancement of sleep with a growth hormone secretagogue
11/13/1997	CA2204846A1 Pharmaceutical compounds
11/12/1997	EP0806423A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
11/12/1997	EP0806419A1 Benzoxazole derivatives as serotonin 5-HT3 receptor partial activator
11/12/1997	EP0806416A1 Huperzine a derivatives, their preparation and their use
11/12/1997	EP0805862A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
11/12/1997	EP0805820A1 Ligands for eph-like receptors
11/12/1997	EP0805812A1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists
11/12/1997	EP0805809A2 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists
11/12/1997	EP0805802A1 Substituted phenyl compounds as endothelin antagonists
11/12/1997	EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof
11/12/1997	EP0805680A2 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
11/12/1997	EP0690850B1 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists
11/12/1997	CN1164858A Trophic factors for central nervous system regeneration
11/12/1997	CN1164856A Novel alkylamino derivatives as sigma 2 selective ligands
11/12/1997	CN1164537A New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions contianing them
11/12/1997	CN1036393C 7-(2-aminoethyl)-benzothiazolones
11/12/1997	CN1036392C Method for preparation of ring-substituted 2-amino-tetralin and 3-aminochromanes
11/12/1997	CN1036389C Phenylacetyl deriv. of 4-amino-2,6-dimethyl phenylsulfonyl-nitro-methane or preparing process thereof
11/11/1997	US5686622 Thiazolidine derivatives, their preparation and the medicaments containing the same
11/11/1997	US5686615 Stereoselective preparation of substituted piperidines
11/11/1997	US5686614 Preparation of chiral 5-aminocarbonyl-5H-dibenzo a,d!cyclohepten-5,10-imines by optical resolution
11/11/1997	US5686609 Aromatic amine compounds, Their method of preparation and pharmaceutical compositions in which they are present
11/11/1997	US5686496 Aromatic ether amidine used for treating diseases involve inflammatory and/or allergic processes
11/11/1997	US5686495 Substituted hydrazinedicarboximidamides and methods of use thereof
11/11/1997	US5686483 Aminoalkyloximes
11/11/1997	US5686480 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
11/11/1997	US5686478 Endothelin antagonists
11/11/1997	US5686476 Methods of inhibiting Alzheimer's Disease
11/11/1997	US5686475 Application of riluzole in the treatment of mitochondrial diseases
11/11/1997	US5686473 Treating parkinsons disease, alzheimers disease, dementia and pain
11/11/1997	US5686471 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/11/1997	US5686464 3,3-diphenylpropylamines, their use and preparation
11/11/1997	US5686463 Oxadiazoles useful in the treatment of senile dementia
11/11/1997	US5686462 Anti-inflammatory method
11/11/1997	US5686461 Inhibition of nmda induced convulsions
11/11/1997	US5686460 Antiinflammatory agents, analgesics
11/11/1997	US5686449 1,5-benzodiazepines useful as gastrinor CCK-antagonists
11/11/1997	US5686447 Aminoalkyloximes for treating depression and affective disorders
11/11/1997	US5686446 Antidepressants, obsessive compulsive disorders
11/11/1997	US5686415 Method for the treatment of colon epithelial cells in vivo
11/11/1997	CA2130563C 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist
11/11/1997	CA1339533C T-butyl ergoline derivatives
11/06/1997	WO1997041443A2 Method for screening compounds
11/06/1997	WO1997041231A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/06/1997	WO1997041222A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS
11/06/1997	WO1997041147A1 Novel compounds
11/06/1997	WO1997041127A1 Halo-substituted protein kinase c inhibitors
11/06/1997	WO1997041125A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
11/06/1997	WO1997041120A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
11/06/1997	WO1997041099A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	WO1997041098A1 Azetidinone derivatives for the treatment of atherosclerosis

1 ... 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 ... 1833